MeSH term
Frequency | Condition_Probility | Animals | 37 | 0.0 |
Female | 6 | 0.0 |
Humans | 78 | 0.0 |
Male | 4 | 0.0 |
Mice | 25 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Proto-Oncogene Proteins/genetics/*physiology | 2 | 2.0 |
Research Support, Non-U.S. Gov't | 62 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 47 | 0.0 |
Signal Transduction/physiology | 3 | 0.0 |
*Adaptor Proteins, Signal Transducing | 72 | 5.0 |
Cytoskeletal Proteins/metabolism | 2 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Mutation | 4 | 0.0 |
Nuclear Proteins/*metabolism | 25 | 3.0 |
Phosphoproteins/metabolism | 9 | 1.0 |
Trans-Activators/metabolism | 4 | 0.0 |
Tumor Cells, Cultured | 24 | 0.0 |
rac1 GTP-Binding Protein/metabolism | 2 | 2.0 |
rap1 GTP-Binding Proteins/metabolism | 2 | 11.0 |
src Homology Domains | 20 | 3.0 |
Cells, Cultured | 7 | 0.0 |
Enzyme Activation | 8 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Guanine Nucleotide-Releasing Factor 2/metabolism | 2 | 66.0 |
Interferon-alpha/*pharmacology | 2 | 1.0 |
Kinetics | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
rap1 GTP-Binding Proteins/*metabolism | 2 | 12.0 |
*Adaptor Proteins, Vesicular Transport | 3 | 1.0 |
Cell Line | 30 | 0.0 |
Interleukin-2/*pharmacology | 3 | 1.0 |
K562 Cells | 4 | 0.0 |
Lymphocyte Activation | 4 | 0.0 |
Nuclear Proteins/physiology | 2 | 2.0 |
Phosphoproteins/physiology | 4 | 6.0 |
Phosphorylation | 50 | 0.0 |
Phosphotyrosine/metabolism | 6 | 1.0 |
Proteins/physiology | 2 | 1.0 |
*Signal Transduction | 10 | 0.0 |
*Ubiquitin-Protein Ligases | 15 | 2.0 |
Erythropoietin/pharmacology | 2 | 1.0 |
Protein-Tyrosine Kinase/metabolism | 7 | 0.0 |
*Proto-Oncogene Proteins | 8 | 0.0 |
Recombinant Fusion Proteins/metabolism | 9 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Transfection | 8 | 0.0 |
Signal Transduction/*immunology | 3 | 0.0 |
Antibodies/pharmacology | 2 | 0.0 |
Binding Sites | 7 | 0.0 |
Protein Binding | 14 | 0.0 |
Signal Transduction | 15 | 0.0 |
src Homology Domains/physiology | 5 | 11.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Nuclear Proteins/metabolism | 11 | 1.0 |
Protein Kinases/metabolism | 2 | 0.0 |
*src Homology Domains | 7 | 3.0 |
Enzyme Precursors/*metabolism | 2 | 1.0 |
Protein-Tyrosine Kinase/*metabolism | 3 | 0.0 |
Proteins/*metabolism | 3 | 0.0 |
COS Cells | 5 | 0.0 |
Immunoblotting | 2 | 0.0 |
Jurkat Cells | 3 | 0.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism | 2 | 3.0 |
Oncogene Proteins/metabolism | 2 | 2.0 |
Plasmids/metabolism | 2 | 0.0 |
Precipitin Tests | 5 | 0.0 |
Proline/metabolism | 2 | 3.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Proteins/metabolism | 6 | 0.0 |
Proto-Oncogene Proteins/metabolism | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Tyrosine/metabolism | 12 | 1.0 |
Retroviridae Proteins, Oncogenic/*metabolism | 2 | 6.0 |
Tyrosine/*metabolism | 7 | 2.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Leukemia, Myeloid, Chronic/*blood | 2 | 33.0 |
Cell Movement/physiology | 3 | 1.0 |
Fusion Proteins, bcr-abl/*metabolism | 9 | 25.0 |
*Milk Proteins | 6 | 1.0 |
Nuclear Proteins/*physiology | 3 | 2.0 |
Antigens, CD29/*metabolism | 4 | 10.0 |
Cell Adhesion | 4 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
DNA Primers | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 5 | 0.0 |
Trans-Activators/*metabolism | 4 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 2 | 0.0 |
Fusion Proteins, bcr-abl/*genetics | 4 | 5.0 |
Phosphoproteins/*metabolism | 12 | 2.0 |
*Tyrosine | 3 | 6.0 |
Cell Differentiation | 3 | 0.0 |
In Vitro | 3 | 0.0 |
Models, Biological | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
HL-60 Cells | 3 | 0.0 |
Molecular Weight | 4 | 0.0 |
3T3 Cells | 4 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Hematopoietic Stem Cells | 2 | 3.0 |
Macromolecular Substances | 3 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Protein Processing, Post-Translational | 3 | 0.0 |
Proto-Oncogene Protein p21(ras)/metabolism | 2 | 2.0 |
Proto-Oncogene Proteins c-abl/metabolism | 2 | 10.0 |
Substrate Specificity | 2 | 0.0 |
Translocation, Genetic | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
src Homology Domains/genetics | 2 | 3.0 |
Interferon Type II/*physiology | 2 | 3.0 |
Protein Binding/genetics | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
Nuclear Proteins/genetics/*physiology | 2 | 4.0 |
Oligonucleotides, Antisense/pharmacology | 2 | 0.0 |
Signal Transduction/*physiology | 6 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 12 | 1.0 |
Insulin-Like Growth Factor I/*pharmacology | 2 | 1.0 |
Interferon-gamma, Recombinant/*pharmacology | 2 | 1.0 |
U937 Cells | 5 | 1.0 |
Phosphorylation/drug effects | 3 | 0.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Fibronectins | 2 | 9.0 |
Guanine Nucleotide Exchange Factors | 5 | 5.0 |
Integrins/*physiology | 2 | 2.0 |
Proteins/*physiology | 2 | 1.0 |
ras Guanine Nucleotide Exchange Factors | 2 | 3.0 |
Blotting, Western | 9 | 0.0 |
Middle Aged | 2 | 0.0 |
Proteins/metabolism/physiology | 2 | 18.0 |
Proto-Oncogene Proteins/*physiology | 2 | 0.0 |
Receptors, IgG/*physiology | 2 | 6.0 |
src-Family Kinases/*physiology | 2 | 5.0 |
*Philadelphia Chromosome | 2 | 2.0 |
Binding Sites/genetics | 2 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
*Proteins | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Adult | 2 | 0.0 |
Leukemia, Myeloid, Chronic/*metabolism | 2 | 18.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
Blood Platelets/drug effects/*metabolism | 2 | 2.0 |
DNA/metabolism | 2 | 0.0 |
Thrombopoietin/*pharmacology | 2 | 2.0 |
Erythropoietin/*pharmacology | 3 | 2.0 |
Hematopoietic Stem Cells/*metabolism | 2 | 1.0 |
Point Mutation | 3 | 0.0 |
Rats | 3 | 0.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 2 | 1.0 |
Phosphotyrosine/analysis | 2 | 3.0 |
Cell Line, Transformed | 6 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Carrier Proteins/*metabolism | 3 | 0.0 |
Hela Cells | 2 | 0.0 |
Son of Sevenless Proteins | 3 | 5.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 2 | 0.0 |
T-Lymphocytes/*metabolism | 2 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Cell Division | 3 | 0.0 |
Cytoskeletal Proteins/*metabolism | 2 | 1.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
Protein Kinases/*genetics | 2 | 1.0 |
Interleukin-3/*pharmacology | 2 | 1.0 |
Nuclear Proteins/isolation & purification/*metabolism | 2 | 6.0 |
1-Phosphatidylinositol 3-Kinase | 2 | 1.0 |
Phosphotransferases (Alcohol Group Acceptor)/*metabolism | 2 | 2.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Fusion Proteins, bcr-abl/metabolism | 3 | 18.0 |
Leukemia, Myeloid, Philadelphia-Positive/*metabolism | 2 | 66.0 |
Phosphotyrosine | 4 | 1.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Fusion Proteins, bcr-abl/blood | 2 | 66.0 |
